Toward a less expensive version of the anti-flu drug Tamiflu

January 13, 2010
A new way of producing the active ingredient in Tamiflu, above, promises to reduce the cost of the widely used anti-flu medication. Credit: Vantey, Wikimedia Commons

Scientists have developed an alternative method for producing the active ingredient in Tamiflu®, the mainstay for fighting H1N1 and other forms of influenza. The new process could expand availability of the drug by reducing its cost, which now retails for as about $8 per dose. Their study is in ACS' Organic Letters.

Anqi Chen, Christina Chai and colleagues note that the global pandemic of H1N1 has resulted in millions of infected cases worldwide and nearly 10,000 deaths to date. Tamiflu®, also known as oseltamivir phosphate, remains the most widely used antiviral drug for the prevention and treatment of H1N1 infections as well as and seasonal influenzas. But growing demand for the drug has put pressure on the supply of shikimic acid, the raw material now used in making the drug.

"As a result, chemists worldwide including ourselves have explored the possibility of using other alternative raw materials for the synthesis of the drug," said Chen and Chai, who led the research.

The scientists describe a new process for making the drug that does not use shikimic acid. They found that D-ribose, a naturally-occurring sugar produced by in large scales, potentially provides an inexpensive and abundant source of starting material for making the drug. D-ribose costs only about one-sixth as much as shikimic acid. In lab studies, the scientists demonstrated the potential use of D-ribose as an alternative source for the synthesis of ®.

Explore further: Yuletide trees may help fight bird flu

More information: "Efficient Formal Synthesis of Oseltamivir Phosphate (Tamiflu) with Inexpensive D-Ribose as the Starting Material", pubs.acs.org/doi/full/10.1021/ol9024716

Related Stories

Old drug may become new bird flu weapon

March 15, 2006

Amantadine, a generic drug created in the 1970s to treat seasonal flu might become a new weapon to use along with Tamiflu if a bird flu pandemic occurs.

Tamiflu Metabolite Found in Sewage Discharge, River Water

October 1, 2009

(PhysOrg.com) -- In a study published September 28th ahead of print in the peer-reviewed journal Environmental Health Perspectives, researchers measured oseltamivir carboxylate (OC), the active metabolite of the popular anti-influenza ...

WHO says Tamiflu still works against swine flu

November 26, 2009

(AP) -- The World Health Organization says isolated cases of drug-resistant swine flu in Britain and the United States have not changed the agency's assessment of the disease.

Drug-resistant swine flu cluster on Vietnam train

December 9, 2009

(PhysOrg.com) -- A cluster of seven people infected with a Tamiflu-resistant strain of pandemic H1N1 influenza has been identified in Vietnam by a team including Oxford researchers.

Recommended for you

How to look for a few good catalysts

July 30, 2015

Two key physical phenomena take place at the surfaces of materials: catalysis and wetting. A catalyst enhances the rate of chemical reactions; wetting refers to how liquids spread across a surface.

Findings illuminate animal evolution in protein function

July 27, 2015

Virginia Commonwealth University and University of Richmond researchers recently teamed up to explore the inner workings of cells and shed light on the 400–600 million years of evolution between humans and early animals ...

Yarn from slaughterhouse waste

July 29, 2015

ETH researchers have developed a yarn from ordinary gelatine that has good qualities similar to those of merino wool fibers. Now they are working on making the yarn even more water resistant.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.